Moderna, Inc. (MRNA) Presents at Jefferies Global Healthcare Conference (Transcript)Seeking Alpha • 06/08/23
Moderna cancer vaccine used with Merck Keytruda reduces risk of deadly skin cancer spreadingCNBC • 06/05/23
Moderna and Merck Announce mRNA-4157 (V940) in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated a Statistically Significant and Clinically Meaningful Improvement in Distant Metastasis-Free Survival in Patients with High-Risk Stage III/IV MelanomaAccesswire • 06/05/23
COVID Concerns Are Rising in China Again: Will This Send Moderna's Stock Soaring?The Motley Fool • 06/01/23
Moderna Announces Phase 2 Data on mRNA-4157 (V940), an Investigational Individualized Neoantigen Therapy, to be Presented at the 2023 ASCO Annual MeetingAccesswire • 05/30/23
Is Moderna Stock A Buy After Unexpectedly Turning A First-Quarter Profit?Investors Business Daily • 05/25/23
Bank Of America Upped Its Forecast For Stocks — Just Not The Ones You ThinkInvestors Business Daily • 05/23/23